首页> 美国卫生研究院文献>Journal of Ocular Pharmacology and Therapeutics >Induced Pluripotent Stem Cell Therapies for Degenerative Disease of the Outer Retina: Disease Modeling and Cell Replacement
【2h】

Induced Pluripotent Stem Cell Therapies for Degenerative Disease of the Outer Retina: Disease Modeling and Cell Replacement

机译:外视网膜变性疾病的诱导多能干细胞疗法:疾病模型和细胞置换。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Stem cell therapies are being explored as potential treatments for retinal disease. How to replace neurons in a degenerated retina presents a continued challenge for the regenerative medicine field that, if achieved, could restore sight. The major issues are: (i) the source and availability of donor cells for transplantation; (ii) the differentiation of stem cells into the required retinal cells; and (iii) the delivery, integration, functionality, and survival of new cells in the host neural network. This review considers the use of induced pluripotent stem cells (iPSC), currently under intense investigation, as a platform for cell transplantation therapy. Moreover, patient-specific iPSC are being developed for autologous cell transplantation and as a tool for modeling specific retinal diseases, testing gene therapies, and drug screening.
机译:正在探索干细胞疗法作为视网膜疾病的潜在疗法。如何在退化的视网膜中替换神经元提出了对于再生医学领域的持续挑战,如果实现,可以恢复视力。主要问题是:(i)供体细胞的来源和可用性; (ii)将干细胞分化为所需的视网膜细胞; (iii)宿主神经网络中新细胞的递送,整合,功能和存活。这篇评论认为诱导多能干细胞(iPSC)的使用,目前正在深入研究中,作为细胞移植治疗的平台。此外,针对患者的iPSC正在开发用于自体细胞移植,并作为建模特定视网膜疾病,测试基因疗法和药物筛选的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号